mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.0065 |
0.8 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.8 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |